- RecruitingPHASE3
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
This extension study is for adults with blood cancers or solid tumours who took part in an earlier trial of a medicine called pelabresib. It aims to check the long-term safety of the drug and see how well it continues to help patients manage their condition over time.
For: Hematologic Malignancy · Solid Tumor · Advanced MalignanciesUnited States · Belgium · Italy - Active not recruitingPHASE3
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
This study is testing a new medicine called pelabresib alongside an existing treatment (ruxolitinib) for adults with myelofibrosis who haven't tried similar drugs before. It aims to see if this combination works better than ruxolitinib alone to help manage symptoms and spleen size.
For: Myelofibrosis · Primary Myelofibrosis · Post-polycythemia Vera MyelofibrosisUnited States · Australia · Austria - RecruitingPHASE1
Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment
This study looks at a new drug, pelabresib, for people with advanced cancers and liver problems. We want to see how the drug works in the body and if it's safe for those with different levels of liver health.
For: Advanced Malignancies and Hepatic ImpairmentFrance · Italy · Spain - RecruitingPHASE1
A Drug-drug Interaction Study to Assess the Effect of Phenytoin and Itraconazole on the Pharmacokinetics of Pelabresib in Healthy Participants
This study looks at how a new medicine, pelabresib, interacts with two common drugs, phenytoin and itraconazole, in healthy people. We want to understand how these drugs affect pelabresib's levels in the body and check for safety.
For: Healthy ParticipantsUnited Kingdom